Hair Loss Treatment

Best Minoxidil for Men: Our Top 5 Brands of 2026

December 16, 2025 /

Commissions we earn from partner links on this page do not affect our opinions or evaluations. Minoxidil is a clinically proven hair-regrowth agent that is one of only two FDA-approved treatments for pattern hair loss. It has consistently yielded favorable outcomes for millions of men worldwide, and its effectiveness is supported by decades of study…

Best Minoxidil for Women: Top 4 Products of 2026

December 16, 2025 /

Commissions we earn from partner links on this page do not affect our opinions or evaluations. Today’s market is saturated with hair-loss products for women, and navigating advertising claims to find effective treatments can be challenging. Top products demonstrate proven efficacy and safety with customization features and affordability to suit a range of female hair-restoration…

Ulo Debuts as the Latest Entrant in the Telehealth Hair Care Industry

June 25, 2025 /

Commissions we earn from partner links on this page do not affect our opinions or evaluations. This isn’t news about future treatments. Instead, this is about a new U.S.-based telehealth brand, Ulo, and its innovative prescription and over-the-counter treatments for hair growth. There are dozens of telehealth hair care brands, yet Follicle Thought has never…

Dermaliq Announced Results From its Phase 1b/2a Trial For DLQ01 For Androgenic Alopecia

July 21, 2024 /

Dermaliq, a clinical-stage dermatology and aesthetics company, has announced topline results from their Phase 1b/2a trial evaluating DLQ01, a topical prostaglandin F2 alpha analog, for the treatment of androgenic alopecia in men.  What is DLQ01? DLQ01 is a topical treatment indicated for male and female pattern baldness that utilizes Dermaliq’s proprietary hyliQ® technology. This formulation…

Lumenis Launches Folix: An FDA-Cleared Fractional Laser For Hair Loss

June 11, 2024 /

Lumenis Be. Ltd, an energy-based medical device company specializing in aesthetic and eye care solutions, has introduced FoLix™, a fractional laser system for treating hair loss. Recently cleared by the FDA, FoLix is the first fractional laser to be cleared for hair loss treatment for both women and men in the United States. What is…

Kintor Releases Phase 2 Trial Results for GT20029

April 24, 2024 /

Kintor Pharmaceuticals has announced that its proteolysis targeting chimera (PROTAC) drug GT20029 has reached its primary endpoint in its Phase 2 trial in China. GT20029 is a topical PROTAC targeted toward AGA.  What are PROTACs? PROTACs are a novel class of heterobifunctional molecules that can induce the degradation of target proteins by hijacking the cell’s…

Androgenetic Alopecia Therapies Master List Pipeline 2025

October 20, 2021 /

This article contains a complete list and description of every known biotech and med-tech company working on a clinical therapy for hair loss prevention/hair growth from all phases spanning research to late-stage clinical trials in 2024/2025. Over the past several years, the amount of new hair growth related technologies in development have multiplied like never…

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.